IQVIA and Salesforce have announced a global partnership, aimed at accelerating the development of the Life Sciences Cloud for enhanced customer engagement. As part of this collaboration, IQVIA will continue to market the OCE and license its solution to Salesforce. The new platform is expected to be available in 2025 and will provide a comprehensive solution tailored to the life sciences industry.
Additionally, Salesforce partnership with IQVIA to jointly market this innovative offering, combining their strengths in data and technology to improve how life sciences organizations interact with healthcare professionals (HCPs) and patients.
What kind of experience do the two partners have in the life sciences industry?
Salesforce Leads the Way in Pharma CRM with Life Sciences Cloud
Salesforce offers a leading Customer Relationship Management (CRM) platform in the pharmaceutical industry. The company intends to develop the platform.
The support comes from Frank Defesche. He is currently serving as the Senior Vice President and General Manager of Life Sciences Cloud at Salesforce. He recently returned to Salesforce after a significant tenure at Veeva Systems, where he played a crucial role in developing solutions tailored for life sciences organizations.
One of Defesche’s key initiatives at Salesforce is the expanded partnership with IQVIA. This collaboration aims to accelerate the development of Salesforce’s Life Sciences Cloud, which is expected to launch in 2025.
QVIA’s Commitment to Patient Privacy and Innovative Solutions for HCP
IQVIA™ is a leading global provider of data, analytics, technology, and services tailored for the life sciences industry. With approximately 87,000 employees operating in over 100 countries, IQVIA serves nearly 400 global OCE customers through its platform.
The company excels in protecting individual patient privacy while leveraging advanced analytics to drive insights that enhance healthcare outcomes. IQVIA’s innovative solutions facilitate the clinical development and commercialization of medical treatments, helping organizations navigate regulatory complexities and improve patient engagement. By connecting healthcare stakeholders with actionable insights, IQVIA plays a crucial role in advancing the life sciences sector and improving patient care worldwide.
Customer Engagement at the Forefront of the Salesforce Partnership with IQVIA
IQVIA and Salesforce are leveraging their combined strengths in data, technology, and industry expertise to create a seamless transition from IQVIA’s Orchestrated Customer Engagement (OCE) platform to Salesforce’s Life Sciences Cloud. This partnership is designed to deliver a single, end-to-end engagement solution that improves interactions between healthcare professionals (HCPs) and patients.
Clinical trial management and operations are at the forefront of the transformation, providing access to IQVIA’s extensive client base, including biotech, medical device and pharmaceutical companies. According to Bernd Haas, SVP at IQVIA, the partnership will “bring the best of our combined data, AI and technology capabilities to life sciences clients”. It is designed to “accelerate decision-making across discovery, clinical development, medical affairs, patient safety, and regulatory compliance”.
Expanded Salesforce and IQVIA Collaboration to Bring AI Capabilities
The recent collaboration between Salesforce and IQVIA is expected to have a significant impact on the life sciences CRM landscape, positioning Salesforce as a formidable competitor to Veeva. The integration of IQVIA’s Orchestrated Customer Engagement platform with Salesforce’s Life Sciences Cloud will transform patient and healthcare professional engagement.
As the life sciences market evolves, driven by advances in generative AI technology, we can expect to see a shift towards specialized vendors addressing niche needs. This strategic alliance strengthens Salesforce’s offering and drives innovation in customer engagement strategies, setting the stage for a new era in the pharmaceutical market.
